德国海德堡大学心血管生物学研究博士后岗位
日期：2008-04-21
来源：丁香人才网
InstitutionUniversity of Heidelberg GermanyPositionPostdoctoral Position in Cardiovascular Biology at the University of Heidelberg GermanyLocationHeidelberg Germany South WestDate PostedApril 18th 200 ...
Institution
University of Heidelberg, Germany
Position
Postdoctoral Position in Cardiovascular Biology at the University ofHeidelberg, Germany
Location
Heidelberg, Germany, South West
Date Posted
April 18th 2008
Date Expires
May 17th 2008
Tags
postdoc, cardiovascular biology, university of heidelberg, medicalschool, germany, and heidelberg
Description
University of Heidelberg
National Genome Research Network (NGFN)
Postdoctoral position
Within the Department of Cardiovascular Physiology of HeidelbergUniversity School of Medicine a position (German remuneration schemeTV-L E13) funded by the Federal Ministry of Research and Education(BMBF) is available from 1 May 2008 for a
Postdoctoral research fellow (m/f).
The position will be funded for a period of three years with thepossibility of extension.
The successful candidate should enjoy interactive teamwork in the fieldof cardiovascular biology and have a qualified PhD or equivalent degreein the life sciences, preferably biochemistry, (human) biology, pharmacyor veterinary medicine. In-depth knowledge of modern cell and molecularbiology methods is a must as well a good command of the English language.
His/her research activities within the funded NGFN-Transfer project“Heart Failure Therapy” will focus on the in vitro validation of thebiological activity of decoy oligodeoxynucleotides, i.e. nucleicacid-based drugs directed against transcription factors which have beenshown to play a pivotal role in the altered gene expression duringmyocardial failure. Therefore, experiences in the handling of human ormouse cardiac myocytes and fibroblasts would be an advantage. Thesuccessful applicant will join a team of three scientists, one PhDstudent and one technician at the University of Heidelberg who workclosely with AVONTEC GmbH, a German biopharmaceutical company addressinglarge-market indication areas with product candidates derived from itsunique and powerful decoy oligodeoxynucleotide platform technology.
Contact
Informal inquiries regarding the position as well as the project shouldbe addressed to the coordinator Professor Markus Hecker (Tel. +49 6221544035, Email hecker@physiologie.uni-hd.de).
Interested? Then submit your curriculum vitae, copies of yourcertificates, a list of publications, and the names of at least twoacademic referees to:
Professor Markus Hecker
Institute of Physiology and Pathophysiology
Department of Cardiovascular Physiology
University of Heidelberg
Im Neuenheimer Feld 326
69120 Heidelberg
Germany
Email laeufer@physiologie.uni-heidelberg.de
Electronic submission is preferred but applications may also be sent byregular mail. The closing date for applications is two weeks afterposting of this advertisement.
University of Heidelberg, Germany
Position
Postdoctoral Position in Cardiovascular Biology at the University ofHeidelberg, Germany
Location
Heidelberg, Germany, South West
Date Posted
April 18th 2008
Date Expires
May 17th 2008
Tags
postdoc, cardiovascular biology, university of heidelberg, medicalschool, germany, and heidelberg
Description
University of Heidelberg
National Genome Research Network (NGFN)
Postdoctoral position
Within the Department of Cardiovascular Physiology of HeidelbergUniversity School of Medicine a position (German remuneration schemeTV-L E13) funded by the Federal Ministry of Research and Education(BMBF) is available from 1 May 2008 for a
Postdoctoral research fellow (m/f).
The position will be funded for a period of three years with thepossibility of extension.
The successful candidate should enjoy interactive teamwork in the fieldof cardiovascular biology and have a qualified PhD or equivalent degreein the life sciences, preferably biochemistry, (human) biology, pharmacyor veterinary medicine. In-depth knowledge of modern cell and molecularbiology methods is a must as well a good command of the English language.
His/her research activities within the funded NGFN-Transfer project“Heart Failure Therapy” will focus on the in vitro validation of thebiological activity of decoy oligodeoxynucleotides, i.e. nucleicacid-based drugs directed against transcription factors which have beenshown to play a pivotal role in the altered gene expression duringmyocardial failure. Therefore, experiences in the handling of human ormouse cardiac myocytes and fibroblasts would be an advantage. Thesuccessful applicant will join a team of three scientists, one PhDstudent and one technician at the University of Heidelberg who workclosely with AVONTEC GmbH, a German biopharmaceutical company addressinglarge-market indication areas with product candidates derived from itsunique and powerful decoy oligodeoxynucleotide platform technology.
Contact
Informal inquiries regarding the position as well as the project shouldbe addressed to the coordinator Professor Markus Hecker (Tel. +49 6221544035, Email hecker@physiologie.uni-hd.de).
Interested? Then submit your curriculum vitae, copies of yourcertificates, a list of publications, and the names of at least twoacademic referees to:
Professor Markus Hecker
Institute of Physiology and Pathophysiology
Department of Cardiovascular Physiology
University of Heidelberg
Im Neuenheimer Feld 326
69120 Heidelberg
Germany
Email laeufer@physiologie.uni-heidelberg.de
Electronic submission is preferred but applications may also be sent byregular mail. The closing date for applications is two weeks afterposting of this advertisement.
微信扫一扫分享资讯
- 相关阅读
我是笔试倒数第一进医院的事业单位考试
所以重点还是博主做事认真和态度端正，对吧。
